1 / 72

Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis

Bulgaria's over-the-counter (OTC) pharmaceuticals market size was valued at $137.5 Mn in 2022 and is estimated to expand at a CAGR of 6.52% from 2022 to 2030 and will reach $227.9 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. To get a detailed report, contact us at - info@insights10.com

Insights4
Download Presentation

Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A sample report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis

  2. This report presents a strategic analysis of the Bulgaria Over The Counter (OTC) Pharmaceuticals Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Bulgaria Over The Counter (OTC) Pharmaceuticals Market, and offers unmatched value, accuracy, and expert insights.

  3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2022 Forecast Period 2023-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  4. Table of Content CONTENT PG. NO. 08-21 1. Over The Counter (OTC) Pharmaceuticals Overview 1.1. Overview 1.2. Bulgaria Overview 1.3. Economic Overview: Bulgaria 1.4. Over The Counter (OTC) Pharmaceuticals Market in Bulgaria 1.5. OTC Market in Bulgaria 1.6. Healthcare Scenario in Bulgaria 1.7. Health Insurance Coverage: Bulgaria 1.8. Budget of the Government for Public Insurance 1.9. Mergers and Acquisitions 22-28 2. Market Size and Forecasting 2.1. Market size and forecasts (Excel and Methodology) 4 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  5. Table of Content CONTENT PG. NO. 2.2. Market Segmentation 2.2.1. By Distribution Channel 2.2.2. By Product 2.2.3. By Drug Formulation 2.2.4. By Drug Type 29-33 3. Market Dynamics 3.1. Market Growth Drivers 3.1.1. Bulgaria OTC Pharmaceuticals Market Driver 1 3.1.2. Bulgaria OTC Pharmaceuticals Market Driver 2 3.1.3. Bulgaria OTC Pharmaceuticals Market Driver 3 3.2. Market Restraints 3.2.1. Bulgaria OTC Pharmaceuticals Market Restraint 1 5 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  6. Table of Content CONTENT PG. NO. 3.2.2. Bulgaria OTC Pharmaceuticals Market Restraint 2 3.2.3. Bulgaria OTC Pharmaceuticals Market Restraint 3 34-42 4. Competitive Landscape 4.1 Key Company Profile 4.1.1.Pfizer 4.1.2.Company 2 4.1.3.Company 3 4.1.4.Company 4 4.1.5.Company 5 4.1.6.Company 6 4.1.7.Company 7 6 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  7. Table of Content CONTENT PG. NO. 4.1.8.Company 8 4.1.9.Company 9 4.1.10.Company 10 43-46 5. Reimbursement Scenario 5.1. Reimbursement Regulation 47-52 6. Methodology & Scope 7 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  8. Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis 1. Overview

  9. 1.1 Global Statistics at a Glance Global Over The Counter (OTC) Pharmaceuticals Market Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 6.1% Revenue change by segment in 2023 $29,360.00 Mn, China Most revenue is generated In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in Bulgaria ▪ 31.1% Total revenue will be generated through online sales by 2023 $18.91 Per person revenue in 2023 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Cold & Cough Largest Segment $145.30bn Revenue in the OTC Pharmaceuticals market in 2023 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative ▪ 9 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  10. 1.1 Global Statistics at a Glance (continued) Europe ~Revenue to reach $xx Bn by 2030 North America ~Market Size of $xx Bn APAC -Fastest CAGR Bulgaria ~Market Size of $xx Bn Africa ~Market Size of $xx Bn Australia ~Market Size of $xx Bn Illustrative Illustrative 10 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  11. 1.2 Bulgaria Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ 6,656,888 Population of Bulgaria in 2023 89 Bn Is the Gross Domestic Product (GDP) in Bulgaria in 2022 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 44.8 years Is the median age in Bulgaria, in 2022 8.52% Of Bulgaria’s GDP is spent on health in 2020 11 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  12. 1.3 Economic Overview: Bulgaria Population of Bulgaria, (2020-2030) GDP of Bulgaria, (2020-2030) XX XX XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 0-14 15-24 25-54 Male 49% Female 51% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 55-64 65+ Illustrative Illustrative 12 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  13. 1.4 Bulgaria Statistics at a Glance Bulgaria OTC Pharmaceuticals Market Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ $1.12 Bn Projected Revenue in the OTC Products segment in 2023 4.82 % Is expected annual growth rate In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in Bulgaria ▪ 92.6% Ask for pharmacists’ advice before buying OTC product Drug Stores & community Pharmacies Leading Distribution channel in Bulgaria In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative ▪ 3500+ Registered pharmacies in Bulgaria $37.9 Bn Is the pharmaceutical sale in the year of 2020 13 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  14. 1.5 OTC Pharmaceuticals in Bulgaria Bulgaria OTC Pharmaceuticals Market Forecast, 2022-2030 (in $Bn) 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the overall OTC market in Bulgaria, which includes the market size, current trends and other details related to the topic ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 14 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  15. 1.6 Healthcare Scenario in Bulgaria Healthcare scenario in Bulgaria is characterized by a robust system that aims to provide universal access to high- quality healthcare services Universal Healthcare: Bulgaria has a universal healthcare system known as Public. It provides Bulgarians with access to subsidized medical services, including visits to general practitioners, specialist consultations, and public hospital services 1. Primary Healthcare: Primary healthcare plays a vital role in Bulgaria's healthcare system. It involves general practitioners (GPs) who serve as patients’ first point of contact. GPs provide preventive care, diagnose and treat common illnesses, and refer patients to specialists when needed 2. Public and Private Healthcare: Bulgaria has a mix of public and private healthcare sectors. Public hospitals are funded by the government and provide free or low-cost services to eligible patients. Private healthcare offers additional services and options for those who have private health insurance 3. Pharmaceutical Benefits Scheme (PBS): The PBS subsidizes the cost of prescription medications, making them more affordable for Bulgarians. Under this scheme, patients pay a reduced price for medications listed on the PBS schedule 4. Aged Care Services: Bulgaria has a well-developed aged care sector to cater to the needs of older adults. It includes residential aged care facilities, home care services, and community-based programs 5. Health Workforce: Bulgaria has a well-trained and diverse healthcare workforce, including doctors, nurses, allied health professionals, and specialists. The country also welcomes international healthcare professionals to address workforce needs 6. Illustrative Illustrative 15 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  16. 1.6 Healthcare Scenario in Bulgaria (continued) Healthcare scenario in Bulgaria is characterized by a robust system that aims to provide universal access to high- quality healthcare services Health Promotion and Prevention: Bulgaria emphasizes health promotion and disease prevention initiatives. Various campaigns and programs focus on promoting healthy lifestyles, disease screening, immunization, and early intervention 7. Digital Health: The adoption of digital health technologies is increasing in Bulgaria. Electronic health records, telehealth services, and digital health platforms are being used to improve access to healthcare and enhance coordination of care 8. Illustrative Illustrative 16 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  17. 1.7 Health Insurance Coverage: Bulgaria % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage Coverage Type 2020 2021 Change % 8.3 Uninsured Total 327,521 328,074 91.7 With health insurance Any health plan 299,230 300,887 0.4 Any private plan 217,896 216,366 –0.6 66.0 Any private plan Employment-based 178,737 178,285 –0.2 54.3 Employment-based Direct-purchase 33,869 33,555 –0.1 10.2 Direct-purchase Marketplace coverage 10,924 11,389 0.1 3.5 Marketplace TRICARE 9,165 8,299 –0.3 2.5 TRICARE Any public plan 112,925 117,095 1.2 58,541 60,226 0.5 35.7 Any public plan 58,778 61,940 0.9 36.4 Public VA and CHAMPVA 2,967 3,151 0.1 1.0 VA and CHAMPVA Uninsured 28,291 27,187 –0.4 In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year More people had private health insurance (66%) than public coverage (35.7%) Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Public (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) ▪ ▪ ▪ Illustrative Illustrative 17 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  18. 1.8 Budget of Bulgaria Government for Public Insurance Proposed Budget By Category Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 In Billions Of Dollars $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 Public 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% As % Of GDP National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Public spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 18 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  19. 1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend $16.7 112 110 107 107 89 82 $11.7 $10.5 $7.7 $6.8 $6.0 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) 39% 41% 41% 42% 58% 59% 59% 61% Strategic Buyers Financial Buyers $0- $25 $25-$50 $50-$100 $100+ 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative Illustrative 19 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  20. 1.9 Mergers and Acquisitions (continued) Latest Deals In Bulgaria Amount / Duration Company Name Type Year Key Pointers Sanofi acquired Provention Bio for about $2.9 Bn, expanding Sanofi's core asset portfolio ▪ Acquisition $2.9 Bn March,2023 This deal introduces a groundbreaking therapy for type 1 diabetes to Sanofi's portfolio ▪ Pfizer announced that it would acquire Seagen, a global biotechnology company that discovers, develops, and commercializes transformative Dermatology medicines ▪ This acquisition is expected to enhance Pfizer's position the segment of Oncology, with Seagen's medicines, late-stage development programs, and pioneering expertise in Antibody- Drug Conjugates (ADCs) strongly complementing Pfizer's Oncology portfolio ▪ Acquisition $43 Bn Mar, 2023 20 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  21. 1.9 Mergers and Acquisitions (continued) Latest Deals In Bulgaria Amount / Duration Company Name Type Year Key Pointers Merger March 2023 Merger Jan 2023 Illustrative Illustrative 21 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  22. Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis 2. Market Size and Forecasting

  23. 2.1 Market Size and Forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption Bulgaria OTC Pharmaceuticals Market Forecast, 2022-2030 (in $Bn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ XX XX In this section you will get an understanding of the overall Healthcare Insurance market in Malaysia, which includes the market size, current trends and other details related to the topic ▪ 2022 2023F 2024F 2025F 2026F 2025 2027F 2026 2028F 2027 2029F 2030F 2023 2024 2028 2029 2030 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Major Markets Patient (Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Bulgaria Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative ▪ % of Bulgarian Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Bulgaria Market Size (Bn $) 61 74 84 87 91 95 99 106 23 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  24. 2.2 Snapshot of Bulgaria OTC Pharmaceuticals Market Segmentation Distribution Channel Product Drug Formulation Drug Type Solid Generic Drug Store & Pharmacy Pain Relivers Hospital Branded-Generic Cold & Cough Liquid Other Dermatological Semi Solid Digestives Weight loss Vitamins & Minerals Other In this section you will get an understanding of the segmentations which will cover the Bulgaria OTC Pharmaceuticals Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Illustrative Illustrative 24 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  25. 2.2.1 Market Segmentation: By Distribution Channel Bulgaria OTC Pharmaceuticals Market Share, By Distribution Channel (2022) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Others In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Hospital Drug Store & Pharmacy Illustrative Illustrative 25 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  26. 2.2.2 Market Segmentation: By Product Bulgaria OTC Pharmaceuticals Market Share, By Product (2022) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Other Vitamins & Minerals In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Pain Relivers Weight Loss Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Digestives Dermatological Cold & Cough Illustrative Illustrative 26 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  27. 2.2.3 Market Segmentation: By Drug Formulation Bulgaria OTC Pharmaceuticals Market Share, By Drug Formulation (2022) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Semi Solid In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Solid Spray Liquid Illustrative Illustrative 27 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  28. 2.2.4 Market Segmentation: By Drug Type Bulgaria OTC Pharmaceuticals Market Share, By Drug Type(2022) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Branded Generic Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Genric Illustrative Illustrative 28 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  29. Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis 3. Market Dynamics

  30. 3.1 Market growth drivers 3.1.1 According to the World Bank, the gross national income per capita (which reflects the disposable income) increased from $9,530 in 2020 to $13,250 in 2022 In Indonesia, as more people enter the middle class, there is a greater demand for self-medication and healthcare products, which drives the growth of the OTC market ▪ Disposable Income in Bulgaria Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2020 2030 Illustrative Illustrative 30 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  31. 3.1 Market growth drivers (continued) 3.1.2 43% of the population considered themselves self-medicated, based on a population survey in Bulgaria Self Medication Trend among Indonesians category-by-category To save time, 63.9% of individuals opt for OTC medications as it takes around 5- 10 minutes ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Country Name Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative Axis Title 31 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  32. 3.1 Market growth drivers (continued) 3.1.3 In 2020, Bulgaria's healthcare spending rose by 22.76% to $857, compared to $698 in 2019 Increased healthcare spending result in better overall healthcare infrastructure, improved healthcare services, and increased healthcare coverage. This lead to better diagnosis and treatment of various health conditions, which in turn can potentially reduce the need for OTC medications ▪ Healthcare Spending in Bulgaria Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2010 2020 2020 2030 2030 Illustrative Illustrative 32 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  33. 3.2 Market restraints 3.2.1 Despite experiencing robust growth, healthcare spending remains the lowest in Europe 3.2.2 OTCs are patient-funded, and their use is solely at the discretion of individuals 3.2.3 Restricted Regulation around sales of OTC drugs In 2019, Bulgaria had the lowest per capita health expenditure in the EU at $1,462, adjusted for purchasing power differences. Insurance does not cover over-the- counter drugs, impacting the affordability of these medications for certain consumers Manufacturers are restricted from increasing the registered maximum sales price of OTCs by an amount exceeding the relevant inflation percentage during the period beginning from the date of the last price registration ▪ ▪ ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 33 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  34. Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis 4. Competitive Landscape

  35. 4.1 Key Company Profile Key Note: 1 Pfizer Here is the list of top 10 companies which will cover in the final report ▪ 2 Abbott Each company will have slides for ▪ 3 Johnson & Johnson Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Illustrative Illustrative o o 4 Bayer o o 5 Apteka Mareshki o 6 o GlexoSmithKline o 7 Sanofi o 8 Procter & Gamble ▪ 9 Novartis ▪ 10 Sopharma Trading 35 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  36. 4.1.1 Pfizer Solutions offered Founded in: 1849 ▪ Pfizer is a leading global pharmaceutical company which is one of the dominant player in the Australia ▪ It is committed to developing and commercializing premium medicines which are safe, effective as well as affordable ▪ Pfizer's research and development costs for the twelve months ending September 30, 2023, rose by 1.97% compared to the previous year, reaching $11.480 Bn HQ: New York, USA ➢ Diagnostics ➢ Biologics and Dermatology Drug Type: Private ➢ Pharmaceuticals Revenue: $100.3 Bn (global) ➢ Veterinary products Website: www.pfizer.com Recent Activity / Press Coverage Some of the OTC Drug offered by Pfizer Treat headaches, backaches, muscle aches, etc. Advil Oct 2023: Pfizer has recently received FDA approval for its Dermatology Drug ABRILADA™, which is one of only two Dermatology Drug that are interchangeable with Humira® Aids in the absorption of calcium Caltrate Provides effective relief from cough and cold symptoms Oct 2023:Pfizer Australia and BioNTech have received approval from the Therapeutic Goods Administration (TGA) for their monovalent COVID-19 vaccine adapted to the Omicron XBB.1.5 variant Robitussin Provides heartburn relief Nexium Illustrative Illustrative 36 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  37. 4.1.1 Pfizer (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Pfizer announced that it would acquire Seagen, a global biotechnology company that discovers, develops, and commercializes transformative Dermatology medicines ▪ This acquisition is expected to enhance Pfizer's position the segment of Oncology, with Seagen's medicines, late-stage development programs, and pioneering expertise in Antibody- Drug Conjugates (ADCs) strongly complementing Pfizer's Oncology portfolio ▪ Acquisition $43 Bn Mar, 2023 Seagen Inc. Pfizer acquired Arena Pharmaceuticals, a clinical-stage startup creating novel potential treatments for the treatment of various immuno-inflammatory illnesses ▪ Acquisition $6.7 Bn Mar, 2022 This acquisition granted Pfizer access to Arena's portfolio of potential treatments for the fields of gastrointestinal, dermatology, and cardiology ▪ Arena Pharmaceuticals Illustrative Illustrative 37 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  38. 4.1.1 Pfizer (continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 38 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  39. 4.1.2 Company2 Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for Cancer Recent Activity / Press Coverage Drugs Indications Illustrative Illustrative 39 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  40. 4.1.2 Company2 (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners Illustrative Illustrative 40 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  41. 4.1.2 Company2 (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 41 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  42. 4.1.2 Company2 (continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 42 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  43. Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis 5. Reimbursement Scenario

  44. 5.1 Reimbursement Regulation Government provide health insurance coverage for more than 4 in 10 Population There is no national reimbursement system for OTC Pharmaceuticals in Bulgaria. The Ministry of Health (MoH), the National Council on Prices and Reimbursement of Medicinal Products, and the Health Technology Assessment Commission collectively oversee the drug policy. 1. National Council on Prices and Reimbursement of Medicinal Products: Other Public 1% Endorses and records prices for medicinal products, encompassing those listed in the Positive Drug List ▪ Other Private 3% Uninsured 9% Authorizes pharmaceutical therapeutic guidelines and offers recommendations for treatment algorithms involving medicinal products ▪ 17% Monitors the distribution of medicinal products with established prices ▪ Social health insurance scheme: Bulgaria's health system operates under mandatory social health insurance (SHI), supplemented by limited voluntary health insurance. The National Health Insurance Fund (NHIF), represented by its 28 regional branches, exclusively acts as the purchaser of health services within the SHI framework. 2. 21% Employer-Sponsored 49% Employer-sponsored health insurance: In Bulgaria, employees receive 8% compulsory health insurance, granting access to essential medical services. Employers contribute 4.8%, and the insured employee covers the remaining 3.2% 3. Health Insurance Coverage, 2022 Illustrative Illustrative 44 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  45. 5.1 Reimbursement Regulation (continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) Government Expenditure Public Healthcare Coverage Private Health Insurance Out of Pocket Private Coverage Other NA NA 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023  Public healthcare coverage is provided by the government and includes programs like Public and Private  Public is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities  Private is a joint federal-state program that provides healthcare coverage to individuals with low income and limited resources 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Reimbursement Market Trends ▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs ▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative Illustrative 45 A Sample Report on Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis I Confidential

  46. Bulgaria Over The Counter (OTC) Pharmaceuticals Market Analysis 6. Methodology & Scope

  47. Research Methodology Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources For forecasting, the following parameters are considered: ❑ Market drivers and restraints along with their current and expected impacts ❑ Technological scenario and expected developments ❑ End use industry trends and dynamics ❑ Trends in the consumer behavior ❑ Regulatory scenario and expected developments ❑ Current capacity and expected capacity additions up to 2030 We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time- sensitive, reflecting the most recent value and volume of the market across regions All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs) Currency used in the report is the US dollar (USD), with the market size indicated in USD Million/Billion (Mn/Bn) ▪ ▪ ▪ ▪ ▪ ▪ ▪

  48. Analysis Methodology Our Analysis Methodology involves three critical stages: Data Collection Market Data Analysis & Statistical Model Interpretation & Presentation Secondary Research Analysis & Interpretation Market Trends Primary Research Market Sizing & Analysis Insights Proprietary Database Presentation & Reporting Data Triangulation & Validation

  49. Data Triangulation & Data Validation Top Down Approach Final Market Size Final Market size break up to rest of segmentation Validation from Primary Interview Arriving at market size of each segment Summarization of revenue generated from companies to arrive at total market size Validation from Primary Interview Revenue generated by products & services offered by companies Final Summary Bottom Up Approach

  50. Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

More Related